It's All About-Nonprofit Foundation-Jersey City-Researching Type 1 Diabetes
Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Here is a full list of video credits http://broadcaster.beazil.net/public/credits/youtube/videos/41814 JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
JDRF aims to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition. Type 1 diabetes (Juvenile Diabetes) is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.
In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
18.2 million people in the United States (6.3 percent of the population) have been diagnosed with diabetes. 5 to 10 percent of all people with diabetes have Type 1 Diabetes (T1D). Jersey City, city (1990 pop. 228,537), seat of Hudson co., NE N.J., a port on a peninsula formed by the Hudson and Hackensack rivers and Upper New York Bay, opposite lower Manhattan; settled before 1650, inc. as Jersey City 1836. The second largest city in the state and a commercial and industrial center surpassed only by Newark, it is a port of entry and a manufacturing center. With 11 mi (17.7 km) of waterfront and significant rail connections, Jersey City is an important transportation terminal point and distribution center. It has railroad shops, oil refineries, warehouses, and plants that manufacture a diverse assortment of products, such as chemicals, petroleum and electrical goods, textiles, and cosmetics. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To draw the conclusion, let’s identify the main points –
JDRF family,life-changing breakthroughs,fasting plasma glucose,prediabetes,2-h PG value,grassroots fundraising,IDDP program,prevention,The Walk to Cure Diabetes,hyperglycemia,Jump to cure Diabetes,Diabetic Ketoacidosis,HHNS,Young Leadership Committee,Neuropathy,estimated average glucose,very-low-density lipoprotein cholesterol,insulin therapy,donate to help,DILfrequency study,insulin adjustment,preventive therapies,brittle diabetes,elevated insulin levels,neonatal diabetes,save a life,no insulin production,Juvenile Diabetes charity,Premixed insulin,take action,DPP,Blood Glucose,diabetes advocacy,noninsulin treated patients,heart attack,SDP,diabetes insipidus,Juvenile diabetes foundation,diabetic retinopathy,fasting plasma glucose value,Medtronic Minimed Insulin Pump Users,OneWalk,precise,Pre- Diabetes,Blood Glucose Level,The Foreigner State,Random Plasma Glucose Test,Cure research,insulin aspart,TRIAD study,Non-Profit Organization,repaglinide,diabetic ketoacidosis,cholesterol levels,Oral Glucose Tolerance Test,diabetes mellitus,gestational diabetes,insulin deficiency,insulin analogues,HAPO Study,Children’s Congress,blood pressure,Health line,Apidra,insulin reaction,insulin glulisine,T1DLooksLikeMe,diabetes.